OR WAIT null SECS
LifeTree eClinicalTM, a member of the FFF Enterprises Inc. family of companies and a leading provider of clinical electronic data capture and analysis systems, today announced that the company has entered into a partnership with Novotech, a full service contract research organization (CRO) based in Australia.
Temecula, Calif., June 21, 2005, LifeTree eClinicalTM, a member of the FFF Enterprises Inc. family of companies and a leading provider of clinical electronic data capture and analysis systems, today announced that the company has entered into a partnership with Novotech, a full service contract research organization (CRO) based in Australia. Novotech will partner with LifeTree through its ClinPartnersTM program to provide a suite of clinical services interfaced with the LifeTree eClinical applications.
By combining their capabilities, LifeTree and Novotech offer clinical trial sponsors one of the most comprehensive clinical trial services packages available today, including clinical trial management and monitoring; electronic data capture, analysis and reporting, data and project management, and regulatory affairs. Together, Novotech and LifeTree will accelerate every aspect of a study, from trial site performance through tactical decisions -- even strategic decision-making on the viability of the clinical protocol.
"For multicenter trials, the partnership between Novotech and LifeTree eClinical provides comprehensive and cost-effective solutions for clinical drug development," said Gary Gabriel, vice president of business development for LifeTree. "Coupling Novotech's clinical drug development services with LifeTree's automated data collection and analysis technology, enables a wide range of clinical trial operations. This is an important global relationship for the ClinPartners program."
The ClinPartners program offers CROs two innovative solutions for online clinical trial needs. The technology component is available in three levels, ranging from full installation of the company's electronic suite, LifeTree ICTM, on the CRO's server to hosting of the CRO's studies by LifeTree; the business component involves various levels of sales and marketing support that channel clinical study opportunities to LifeTree's ClinPartner members.
"Partnering with LifeTree allows Novotech to enhance the benefits of cost-effective clinical program management services in Australia for U.S. companies," said Alek Safarian, CEO of Novotech in Australia. "Optimal use of electronic trial management solutions provided by LifeTree eClinical promises to provide faster trial outcome data, greatly benefiting our clients."
About LifeTree eClinical
LifeTree eClinical, also known as LifeTree Technology LLC, is a member of the FFF Enterprises Inc. family of companies, headquartered in Temecula, California. The LifeTree suite of clinical technologies and services has been used in Phase I through IV trials, patient registries and diagnostic and epidemiological studies. The LifeTree ICTM component of the LifeTree eClinical suite provides tools for clinical study design, data entry and data reporting. The suite is completely workflow driven and contains extensive clinical trial metrics and trial management tools that are built-in for designated roles within the clinical trial process. SAS data on demand and a complete menu for building data reports fully empower a study's data analyst. LifeTree ICTM's newest features include comprehensive patient-safety reporting, medical coding and capabilities for handling image data. The clinical data is fully audit trailed, and it is CDISC and 21 CFR Part 11-compliant. For more information, call 800-211-2799 ext 1356, email firstname.lastname@example.org or visit www.lifetreeclinical.com.
Increasingly, U.S. companies are turning to Australia to expedite the pace, and reduce the cost, of clinical trials, while maintaining the high standard of research that U.S. authorities demand. As the largest independent CRO in Australia, Novotech offers a level of flexibility and local knowledge that is virtually unmatched among other contract research organizations in the region. This has helped Novotech develop a strong client base in the United States and Europe.
Headquartered in Sydney, Novotech is focused on the Australian and New Zealand markets, but has worldwide reach through the company's subsidiary in the United Kingdom and through key external partnerships and strategic alliances in North America and other regions. For more information, visit www.novotech-cro.com.